SCHEMBL29659564

SCHEMBL29659564

CN(C)c1nc(NCc2cccc(O)c2)c2ncn(C3CCCCO3)c2n1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ ADORA3 P0DMS8 5/20 0.50
▸ YTHDC1 Q96MU7 1/20 0.46
▸ CTSL P07711 1/20 0.46
▸ FLT3 P36888 1/20 0.44
▸ CCNE2 O96020 1/20 0.44
▸ CCNE1 P24864 1/20 0.44
▸ CDK2 P24941 1/20 0.44
▸ CDK1 P06493 4/20 0.44
▸ CCNB2 O95067 2/20 0.43
▸ CCNB1 P14635 2/20 0.43
▸ CCNB3 Q8WWL7 2/20 0.43
▸ ADORA1 P30542 3/20 0.42
▸ ADORA2A P29274 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547428 1.00 NPC1 (0.56) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL29659545 0.97 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL20547433 0.97 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL29659693 0.90 NPC1 (0.57) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL29659641 0.89 NPC1 (0.69) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL20547199 0.89 NPC1 (0.69) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL20547489 0.87 YTHDC1 (0.61) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL30409810 0.87 NPC1 (0.58) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL21954485 0.87 NPC1 (0.65) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1
SCHEMBL29659622 0.87 NPC1 (0.65) NPC1RAB9ASMN1; SMN2ADORA3YTHDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 — — EP disclosed
Send feedback